國家衛生研究院 NHRI:Item 3990099045/8202
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 917178      線上人數 : 1498
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8202


    題名: PTP4A3 overexpression predicts clinical aggressiveness in urothelial carcinoma
    作者: Yeh, HC;Wu, WJ;Huang, CN;Li, CC;Ke, HL;Li, WM;Li, CF;Lee, YY;Lin, HH;Yeh, BW;Hwang, SJ;Liang, PI
    貢獻者: National Institute of Cancer Research
    摘要: Background: Data mining from a published transcriptome of urinary bladder urothelial carcinomas (GSE32894), PTP4A3was identified as the most significantly upregulated gene among those related to prenylated protein tyrosine phosphatase activity (GO: 0004727). We therefore analysed PTP4A3 transcript and protein expression and their clinicopathological and prognostic significance in our well-characterised cohort of urothelial carcinomas. Methods: PTP4A3 transcript level was assessed in 23 samples of urothelial carcinoma of the urinary bladder with laser capture microdissection coupled with real-time qRT-PCR. PTP4A3 protein expression was determined by immunohistochemistry and evaluated by using H-score in 296 urinary bladder urothelial carcinomas and 340 upper urinary tract urothelial carcinomas, respectively. Both transcript and protein expression statuses were further correlated with clinicopathological features and protein expression was tested for disease-specific survival (DSS) and metastasis-free survival (MeFS). Findings: PTP4A3 transcripts were markedly upregulated in deeply invasive urothelial carcinomas (p < 0.001). For both urinary tract and urinary bladder urothelial carcinomas, PTP4A3 protein overexpression was significantly associated with advanced pT status (both p < 0.001), nodal metastasis (both p < 0.001), and vascular invasion (both p < 0.001). PTP4A3 overexpression not only predicted worse DSS (both p < 0.0001) and MeFS (upper urinary tract, p < 0.0001; urinary bladder, p = 0.0005) at univariate analysis, but also inferior DSS (upper urinary tract, p = 0.001; urinary bladder, p < 0.001) and MeFS (upper urinary tract, p = 0.001; urinary bladder, p = 0.007) in multivariate analysis. Interpretation: PTP4A3 overexpression is an independent prognosticator for urothelial carcinoma, suggesting its potential prognostic and therapeutic value in urothelial carcinoma.
    日期: 2014-05
    關聯: European Journal of Cancer. 2014 May;50(Suppl. 4):e42-e43.
    Link to: http://dx.doi.org/10.1016/j.ejca.2014.03.163
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0959-8049&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000351589200119
    顯示於類別:[其他] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    SDO0959804914004353.pdf43KbAdobe PDF494檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋